英特格拉生命科學 IART 深 滬
已收盤 07-31 16:00:00 美东时间
16.65
-0.470
-2.75%
華盛通- 最 高17.59
- 今 開17.15
- 成交量 93.51万股
- 最 低 16.24
- 昨 收 17.12
- 總市值 12.95亿
- 52周最高 20.49
- 市盈率 靜 --
- 換手率 1.20%
- 52周最低 8.70
- 委 比 84.62%
- 總股本 7779.69万
- 歷史最高 77.40
- 量 比 0.64
- 振 幅 7.89%
- 歷史最低 8.70
- 每 手 1
- 風險率 2.70%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
Integra Lifesciences Sees Q3 Adj EPS $0.53-$0.61 vs $0.56 Est; Sees Sales $410.000M-$425.000M vs $418.100M Est
Integra Lifesciences (NASDAQ:IART) is looking for Q3 Adj EPS of $0.53-$0.61 vs $0.56 analyst estimate. sees sales of $410.000 million-$425.000 million vs $418.100 million analyst estimate.
07-29 18:08
美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元
07-29 11:37
UBS Initiates Coverage On Integra Lifesciences with Neutral Rating, Announces Price Target of $19
UBS analyst Patrick Wood initiates coverage on Integra Lifesciences (NASDAQ:IART) with a Neutral rating and announces Price Target of $19.
07-29 02:21
美股大行评级 | 阿斯麦、贝莱德、纽约梅隆银行、信达思、JB亨特运输服务、美国制商银行、PNC金融服务集团等获多家大行集体上调目标价
今日重点评级关注：瑞杰金融：维持Electrovaya"强力买入"评级，目标价从14美元升至22美元；BTIG：维持vTv Therapeutics"买入"评级，目标价从49美元升至57美元
07-17 11:35
Truist Securities Maintains Hold on Integra Lifesciences, Raises Price Target to $19
Truist Securities analyst Ravi Misra maintains Integra Lifesciences (NASDAQ:IART) with a Hold and raises the price target from $14 to $19.
07-17 00:10
Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026
Integra LifeSciences Holdings Corporation (NASDAQ: IART) will release its second quarter 2026 financial results on July 29, 2026, before the market opens. A conference call with the management team will be held at 8:30 a.m. ET on the same day. A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. Participants can register here to receive dial-in details and a pin. Joining 10 minutes before...
07-16 12:00
美股大行评级 | 潜在涨幅246.92%！HC Wainwright & Co.上调Rockwell Medical(RMTI)目标价至20美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Rockwell Medical"买入"评级，目标价从2美元升至20美元；Canaccord Genuity：维持创力"买入"评级，目标价从10.5美元升至11美元
07-10 17:36
One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics
Issued on behalf of Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ: CNXU) completed the 12-month P.R.O.O.F phase of its CXU preclinical program, which met its objectives across three pi...
07-09 20:16
美股大行评级 | 潜在涨幅215.37%！摩根士丹利上调TeraWulf(WULF)目标价至72美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持TeraWulf"超配"评级，目标价从66.5美元升至72美元；HC Wainwright & Co.：维持Vera Therapeutics"买入"评级，目标价从110美元升至125美元
07-09 12:35
